Arkolith/Insider Trading/IMNM/Form 4

Lechleider Robert

Chief Medical OfficerImmunome Inc. (IMNM) · full profile →Form 4 · filed Jun 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2026Option exercise(M)55K$8.73$480K71K
Jun 25, 2026Sell(S)41K$19.56$794K30K
Jun 25, 2026Sell(S)14K$20.66$298K16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 25, 2026Option exercise(M)55K—$0345K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001997584-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML